Eastwood Bio-Medical Canada Inc
XTSX:EBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Harbin Medisan Pharmaceutical Co Ltd
SZSE:002900
|
CN |
|
Shen Zhen Shengxunda Technology Co Ltd
SZSE:300518
|
CN |
|
Chewy Inc
NYSE:CHWY
|
US |
|
GIFT Holdings Inc
TSE:9279
|
JP |
|
I
|
Inox Green Energy Services Ltd
NSE:INOXGREEN
|
IN |
|
I
|
Inmobiliaria San Patricio SA
SGO:ISANPA
|
CL |
|
Macrotech Developers Ltd
BSE:543287
|
IN |
Eastwood Bio-Medical Canada Inc
Long-Term Debt
Eastwood Bio-Medical Canada Inc
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Eastwood Bio-Medical Canada Inc
XTSX:EBM
|
Long-Term Debt
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Long-Term Debt
$20.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Long-Term Debt
CA$242.3m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
52%
|
|
|
Cronos Group Inc
TSX:CRON
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Long-Term Debt
$40.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Long-Term Debt
CA$57.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
87%
|
CAGR 10-Years
N/A
|
|
Eastwood Bio-Medical Canada Inc
Glance View
Eastwood Bio-Medical Canada, Inc. is a natural health supplement distribution company. The company is headquartered in Richmond, British Columbia. The company went IPO on 2014-09-05. The firm is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients. The Eleotin products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. The firm's licensed products include Eleotin A 700, which is a treatment for spleen deficiency, lack of appetite and fatigue; Eleotin AL88, a laxative; Eleotin Cal20, for bone and teeth maintenance; Eleotin V3D for the development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55, a sedative and tension relief, Eleotin Zn330, which is involved in tissue formation and metabolism; Eleotin Bentley, which is used to promote healthy glucose levels, and Eleotin LBM, which is recommended for hypertension relief.
See Also
What is Eastwood Bio-Medical Canada Inc's Long-Term Debt?
Long-Term Debt
0
CAD
Based on the financial report for Jan 31, 2026, Eastwood Bio-Medical Canada Inc's Long-Term Debt amounts to 0 CAD.